News
-
-
COMMUNIQUÉ DE PRESSE
Positive Outlook: Cannabis Legalization Review and Trump’s Endorsement Send Encouraging Signals
SYNBIOTIC SE enters Q4 2025 optimistically amidst positive signals from cannabis legalization review and Trump's endorsement. Initial evaluation supports current Cannabis Consumption Act -
-
-
COMMUNIQUÉ DE PRESSE
Across the pond: SYNBIOTIC attracts international investors with established intercontinental networks
SYNBIOTIC SE partners with North American fund raising specialists and established multipliers, attracting international investors for its buy-and-build strategy in medical cannabis and industrial hemp sector -
-
-
COMMUNIQUÉ DE PRESSE
Revenue expected to triple by 2027: Focus on growth markets for medical cannabis and industrial hemp underscores positive outlook for SYNBIOTIC
SYNBIOTIC SE expects to triple revenue by 2027 focusing on growth markets for medical cannabis and industrial hemp. Strategic expansion targets booming sectors -
-
